Hein, Marc D.
Kollmus, Heike
Marichal-Gallardo, Pavel
Püttker, Sebastian
Benndorf, Dirk
Genzel, Yvonne
Schughart, Klaus
Kupke, Sascha Y. http://orcid.org/0000-0003-3943-9718
Reichl, Udo
Funding for this research was provided by:
Helmholtz-Gemeinschaft
Article History
Received: 5 September 2020
Revised: 14 November 2020
Accepted: 22 November 2020
First Online: 4 December 2020
Compliance with ethical standards
:
: A patent for the use of OP7 as an antiviral agent is pending (EP18159908). Patent holders are SK and UR. The remaining authors declare no conflict of interest.
: All experiments in mice were approved by an external committee according to the national guidelines of the animal welfare law in Germany (BGBl. I S. 1206, 1313 and BGBl. I S. 1934). The protocol used in these experiments has been reviewed by an ethics committee and approved by the relevant authority, the ‘Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany’ (Permit Number: 33.19.42502-04-18/2922).
: Not applicable.
: Not applicable.